• Targeting Glutamine Metabolism in Hepatic Stellate Cells to

  2026-05-13

  This study establishes that glutamine metabolism, specifically via glutamate dehydrogenase (GDH) and its regulation by SIRT4, is essential for hepatic stellate cell activation and liver fibrosis progression. Inhibiting GDH or restoring SIRT4 expression in hepatic stellate cells significantly reduces fibrogenesis, providing a mechanistic basis for targeting mitochondrial metabolism in antifibrotic research.

• Macrophage-TIPE2 Axis Controls ASC Ferroptosis in Obesity-Li

  2026-05-13

  This study uncovers how loss of TIPE2 in visceral adipose tissue macrophages drives mitochondrial fragmentation and ferroptosis in adipose stem cells, exacerbating metabolic dysfunction in obesity. The findings clarify immune-metabolic crosstalk and identify TIPE2 as a potential therapeutic target in obesity-associated diseases.

• Diethylmaleate in Oxidative Stress Research: Protocols & Ins

  2026-05-12

  Diethylmaleate is transforming oxidative stress and resistance studies by precisely modulating intracellular glutathione and GST activity. Recent research in insect toxicology highlights its pivotal role in dissecting redox regulation and resistance mechanisms—unlocking new strategies for both experimental design and translational applications.

• AZD-3463 (SKU A8620): Data-Driven ALK/IGF1R Inhibition for L

  2026-05-12

  This article provides scenario-driven guidance for deploying AZD-3463 (SKU A8620) as a reliable ALK/IGF1R inhibitor in cell-based assays. Backed by quantitative data and workflow insights, it addresses real-world challenges in experimental reproducibility, signaling pathway targeting, and product selection for neuroblastoma and related cancer research.

• Escitalopram in Experimental Antidepressant Research Workflo

  2026-05-11

  Escitalopram, the S-(+)-enantiomer of citalopram, fuels selective and reproducible modeling of serotonergic signaling in neuropsychiatric research. This guide delivers advanced workflow strategies, troubleshooting insights, and actionable assay parameters that leverage APExBIO’s high-purity Escitalopram for superior research outcomes.

• GST-Mediated Resistance to Lambda-Cyhalothrin in M. usitatus

  2026-05-11

  This study demonstrates that glutathione S-transferase (GST) upregulation is central to Megalurothrips usitatus resistance against lambda-cyhalothrin. Inhibiting GST with diethyl maleate substantially increases insecticide susceptibility by weakening the insect's antioxidant defenses, offering mechanistic insight and practical avenues for oxidative stress and resistance research.

• Simvastatin (Zocor): Reliable Solutions for Cell-Based Assay

  2026-05-10

  This GEO-driven guide addresses real laboratory challenges in cell viability, proliferation, and cytotoxicity assays, demonstrating how Simvastatin (Zocor) (SKU A8522) from APExBIO delivers reproducible, data-backed performance. Scenario-based Q&A—spanning protocol optimization, comparative data, and product reliability—equips biomedical researchers with actionable, evidence-based insights for experimental success.

• GST-Driven Lambda-Cyhalothrin Resistance in M. usitatus

  2026-05-09

  The referenced study establishes that glutathione S-transferase (GST) activity underpins Megalurothrips usitatus resistance to lambda-cyhalothrin by reinforcing antioxidant defenses. Inhibiting GST with diethyl maleate drastically increased insecticide sensitivity, providing mechanistic insight for resistance management and oxidative stress modeling.

• Alternariol Triggers Hepatic Stellate Cell Transdifferentiat

  2026-05-08

  This study elucidates how Alternariol (AOH) and other Alternaria toxins induce hepatic stellate cell (HSC) transdifferentiation—a pivotal event in liver fibrosis—by activating NF-κB, ferroptosis, and autophagy pathways. Integrative omics and mechanistic analysis provide new insights into mycotoxin-induced hepatotoxicity, with laccase-based detoxification proposed as a mitigation strategy.

• Tacalcitol Sensitizes Colorectal Cancer Cells to 5-FU via TS

  2026-05-08

  This study demonstrates that tacalcitol, a synthetic analog of vitamin D3, enhances the sensitivity of colorectal cancer cells to 5-fluorouracil by downregulating thymidylate synthase through vitamin D receptor signaling. The findings suggest a mechanistic rationale for combining tacalcitol with chemotherapy to improve therapeutic outcomes in colorectal cancer.

• M344 as a Potent HDAC Inhibitor Suppressing Neuroblastoma Gr

  2026-05-07

  Brumfield et al. (2025) provide compelling evidence that the histone deacetylase inhibitor M344 suppresses tumor growth and HDAC-driven phenotypes in neuroblastoma. The study demonstrates M344’s superior cytostatic and cytotoxic effects compared to vorinostat, highlighting its promise for preclinical development and improved therapeutic strategies in pediatric oncology.

• Disulfiram as a Dopamine β-Hydroxylase Inhibitor in Cancer R

  2026-05-07

  Disulfiram is redefining translational oncology by combining its role as a dopamine β-hydroxylase inhibitor and copper-dependent proteasome inhibitor, leading to enhanced apoptotic cancer cell death in breast cancer models. This article delivers actionable workflows, troubleshooting guidance, and cross-validated insights to maximize Disulfiram’s impact in cell death and proteasome function studies.

• 3D Organoid–Fibroblast Co-Cultures Model Chemoresistance in

  2026-05-06

  Schuth et al. introduced a three-dimensional co-culture system combining patient-derived pancreatic cancer organoids and matched fibroblasts to model stroma-mediated chemoresistance. This approach reveals key molecular mechanisms driving therapeutic resistance and offers a more physiologically relevant platform for drug response prediction in PDAC.

• Nitrocefin in β-Lactamase Substrate Profiling: Advanced Insi

  2026-05-06

  Explore how Nitrocefin, a chromogenic cephalosporin substrate, empowers advanced β-lactamase assay development and resistance profiling. This article uniquely bridges substrate specificity insights from recent research with practical assay optimization.

• Tropisetron Hydrochloride: Mechanistic Depth & Translational

  2026-05-05

  This thought-leadership article provides translational researchers with a comprehensive, evidence-driven perspective on Tropisetron Hydrochloride. By integrating mechanistic insights into 5-HT3/α7-nicotinic receptor modulation, transporter inhibition, and strategic guidance, it positions APExBIO’s compound as the gold standard for advancing serotonin receptor signaling research. The article draws from peer-reviewed studies and advanced content assets, delivering actionable protocol parameters, competitive benchmarking, and forward-looking perspectives while adhering to strict evidence labeling and SEO best practices.

11574 records 1/772 page Next 12345 下5页 Last page